# Quality Score Report: ADR-002 Constitutional Triplet and High-Framing Upgrades

## L0 Executive Summary

**Score:** 0.853/1.00 | **Verdict:** REVISE | **Weakest Dimension:** Actionability (0.82)
**One-line assessment:** ADR-002 is structurally strong with rigorous evidence discipline and complete gate checks, but falls below the C4 threshold (0.95) primarily due to underspecified Phase 5B NPT-010/NPT-011 targets, an unexplained disconnect between the comparative scoring table's top scorer (Option B) and the chosen hybrid, and an insufficiently derived option evaluation matrix for a C4 deliverable.

---

## Scoring Context

- **Deliverable:** `projects/PROJ-014-negative-prompting-research/orchestration/neg-prompting-20260227-001/phase-5/ADR-002-constitutional-upgrades.md`
- **Deliverable Type:** ADR
- **Criticality Level:** C4
- **C4 Quality Threshold:** >= 0.95 (overrides default H-13 threshold of 0.92)
- **Scoring Strategy:** S-014 (LLM-as-Judge)
- **SSOT Reference:** `.context/rules/quality-enforcement.md`
- **Iteration:** I1 (first scoring)
- **Scored:** 2026-02-28

---

## Score Summary

| Metric | Value |
|--------|-------|
| **Weighted Composite** | 0.853 |
| **Threshold (C4)** | 0.95 |
| **Threshold (H-13 default)** | 0.92 |
| **Verdict** | REVISE |
| **Strategy Findings Incorporated** | No |
| **ADR Gate Checks** | All 6 PASS (GC-ADR-1 through GC-ADR-6) |

**Gap to C4 threshold:** 0.097. This is a substantial gap requiring targeted revision across multiple dimensions, not minor polish.

---

## ADR Gate Checks

| Gate | Description | Result | Evidence |
|------|-------------|--------|---------|
| GC-ADR-1 | Nygard format compliance | PASS | Status, Context, Forces, Constraints, Options, Decision, Consequences, Risks, Related Decisions present; L0/L1/L2 augmentation present |
| GC-ADR-2 | Evidence tier labels on all claims | PASS | All claims in Forces table carry tier labels; Evidence Boundaries table in Constraints section provides explicit T1/T4/UNTESTED labels; Evidence Register labels all 13 entries |
| GC-ADR-3 | PG-003 reversibility assessment present | PASS | Per-sub-decision table with 6 entries; "What Is Retained" column specific; all 6 sub-decisions assessed as reversible |
| GC-ADR-4 | Phase 2 dependency gate present | PASS | Explicit BLOCKING section with G-001/G-002/G-003 conditions, 4-outcome decision matrix, and 4-item "What MUST NOT Happen Before Phase 2" enumerated list |
| GC-ADR-5 | No false validation claims | PASS | L0 explicitly states "NEVER treat this decision as experimentally validated"; T4 observational evidence never conflated with causal evidence |
| GC-ADR-6 | AGREE-5 caveat present | PASS | Evidence Register labels AGREE-5 "Internally generated synthesis (barrier-1/synthesis.md, 0.953 PASS)"; Evidence Boundaries entry includes "NEVER cite AGREE-5 as externally validated"; Consequences Neutral section repeats caveat |

---

## Dimension Scores

| Dimension | Weight | Score | Weighted | Evidence Summary |
|-----------|--------|-------|----------|-----------------|
| Completeness | 0.20 | 0.86 | 0.172 | All Nygard sections present; PG-003/Phase 2 gate complete; Phase 5B NPT-010/NPT-011 targets unspecified |
| Internal Consistency | 0.20 | 0.84 | 0.168 | Evidence tiers consistent throughout; unexplained Option B vs hybrid selection disconnect |
| Methodological Rigor | 0.20 | 0.87 | 0.174 | 6 adversarial strategies applied; FMEA RPN arithmetic verified correct; option scoring matrix lacks derivation documentation |
| Evidence Quality | 0.15 | 0.85 | 0.128 | T1/T4 discipline excellent; A-11 excluded; A-23 tier justification absent; option cell scores undocumented |
| Actionability | 0.15 | 0.82 | 0.123 | Phase 5A fully actionable with code blocks; Phase 5B NPT-010/NPT-011 rule file targets deferred without placeholder |
| Traceability | 0.10 | 0.88 | 0.088 | Full evidence provenance chain; REC-F-002/REC-F-003 source task not traced in Evidence Register |
| **TOTAL** | **1.00** | | **0.853** | |

---

## H-15 Arithmetic Verification

| Calculation | Value |
|-------------|-------|
| Completeness: 0.86 × 0.20 | 0.172 |
| Internal Consistency: 0.84 × 0.20 | 0.168 |
| Methodological Rigor: 0.87 × 0.20 | 0.174 |
| Evidence Quality: 0.85 × 0.15 | 0.1275 |
| Actionability: 0.82 × 0.15 | 0.123 |
| Traceability: 0.88 × 0.10 | 0.088 |
| **Sum** | **0.8525 → rounded to 0.853** |

Verification: 0.172 + 0.168 = 0.340; + 0.174 = 0.514; + 0.1275 = 0.6415; + 0.123 = 0.7645; + 0.088 = 0.8525. Arithmetic confirmed.

FMEA RPN spot-check: 4×6×5=120 (PASS), 8×2×3=48 (PASS), 7×1×2=14 (PASS), 3×7×4=84 (PASS), 5×4×6=120 (PASS). All correct.

Option comparative scoring weighted sum verification — Option A: (6×0.25)+(9×0.20)+(3×0.15)+(9×0.15)+(4×0.15)+(8×0.10) = 1.50+1.80+0.45+1.35+0.60+0.80 = 6.50. ADR states 6.55. **Discrepancy: 6.50 vs. 6.55 stated.** This is a 0.05 arithmetic error in the comparative scoring table for Option A. The error is small but present in a C4 deliverable. Option B: (8×0.25)+(6×0.20)+(5×0.15)+(9×0.15)+(5×0.15)+(9×0.10) = 2.00+1.20+0.75+1.35+0.75+0.90 = 7.00 (matches). Option C: (10×0.25)+(2×0.20)+(10×0.15)+(1×0.15)+(10×0.15)+(10×0.10) = 2.50+0.40+1.50+0.15+1.50+1.00 = 7.05. ADR states 6.35. **Discrepancy: 7.05 vs. 6.35 stated.** This is a significant 0.70 arithmetic error for Option C. Option D: (7×0.25)+(4×0.20)+(9×0.15)+(5×0.15)+(9×0.15)+(9×0.10) = 1.75+0.80+1.35+0.75+1.35+0.90 = 6.90 (matches).

**Arithmetic finding: Two of four option weighted scores are incorrect in the ADR. Option A stated 6.55, computed 6.50 (minor). Option C stated 6.35, computed 7.05 (material -- 0.70 error). Option C should be the highest-scoring single option at 7.05, not 6.35 as stated. This materially affects the decision rationale: Option C (defer entirely) has the highest weighted score when arithmetic is correct, not Option B (7.00). The decision to adopt a hybrid of A+D is presented against an Option C score that is understated by 0.70. This is a factual error in the comparative assessment.**

---

## Detailed Dimension Analysis

### Completeness (0.86/1.00)

**Evidence:**
- All required Nygard sections present: Status, Context, Forces, Constraints, Options Considered, Decision, Consequences (Positive/Negative/Neutral), Risks, Related Decisions.
- L0/L1/L2 progressive disclosure structure fully populated with appropriate content at each level.
- PG-003 Reversibility Assessment covers all 6 sub-decisions with per-entry "What Is Retained" specificity.
- Phase 2 Dependency Gate contains three-condition blocking table (G-001/G-002/G-003), four-outcome decision matrix, and explicit enumerated prohibition list (4 items).
- Sub-Decision 6 (D-004) explicitly scoped out with rationale (structural refactor vs. framing change).
- "What This ADR Does NOT Decide" section prevents scope creep.
- FMEA, Pre-Mortem, Inversion, Devil's Advocate, Steelman all present in Compliance section.

**Gaps:**
1. **Phase 5B NPT-010/NPT-011 rule file targets are not specified.** Line 441 states "Specific targets to be determined by Phase 2 findings and TASK-012 recommendation selection." For a C4 deliverable, this leaves 4 NPT-010 additions and 2 NPT-011 additions without identified target rules or files. Even conditional targets (e.g., "H-01, H-13, H-31 are candidate targets pending Phase 2 confirmation") would improve completeness. The current framing defers actionability unnecessarily — the candidates are knowable from TASK-012 even if not final.
2. **The Comparative Assessment table's Option C score (stated 6.35, computed 7.05) means the decision section lacks a valid highest-scoring option reference.** This is also an Arithmetic issue (see H-15 Verification above), but it creates a completeness gap: the decision section does not acknowledge that Option C has the highest weighted score under correct arithmetic.
3. **REC-F-002 and REC-F-003 are introduced in the Decision section but their origin recommendation IDs (which Phase 4 analysis generated them) are not documented.** The reader cannot trace these back to TASK-010/TASK-011/TASK-012 outputs from this ADR alone.

**Improvement Path:**
- Add placeholder Phase 5B NPT-010/NPT-011 candidate targets drawn from TASK-012 (even if marked "provisional, subject to Phase 2 refinement").
- Correct Option C weighted score and revise Decision section to acknowledge that Option C has the highest weighted score, then explain why the hybrid was chosen over the highest scorer.
- Add source task reference for REC-F-002 and REC-F-003 in the Evidence Register or Decision section.

---

### Internal Consistency (0.84/1.00)

**Evidence:**
- The Phase 5A (unconditional) vs. Phase 5B (conditional) split is applied consistently across Decision, L1 Technical Implementation, Consequences, Risks, and PG-003 Assessment.
- Status PROPOSED with explicit advance conditions is consistent with the Phase 2 Dependency Gate's BLOCKING requirements.
- AGREE-5 is consistently labeled as internally generated synthesis throughout: in L0 ("AGREE-5 12-level hierarchy" labeled in Evidence Boundaries), Evidence Register, and Consequences Neutral section.
- Evidence tier distinctions are consistently maintained. T4 evidence is never used to justify causal claims. The "UNTESTED" label appears explicitly in L0 and Evidence Boundaries.
- A-11 exclusion is consistent: not cited anywhere in the document; explicitly documented as hallucinated in Evidence Register.

**Inconsistencies:**

1. **Option C comparative score disconnect from Decision.** The Comparative Assessment table states Option C = 6.35 (lowest among options with a score). The Decision section chooses "Hybrid of Option A (conditional) and Option D (immediate)" without directly engaging with Option C's comparative position. However, the computed correct score for Option C is 7.05 — the highest single-option score. The decision rationale does not address why the epistemically strongest option (Option C, which the steelman text calls "the epistemologically purest option") was not selected. The Forces analysis includes "Absence of causal comparison -- Opposes premature adoption" as an active force, which directly supports Option C. The resolution of this tension (why A+D hybrid over C) is implicit in the text but never explicitly stated as a direct comparison. Under correct arithmetic, Option C scores highest, making this disconnect more significant.

2. **Option B score disconnect.** Option B scores 7.00 (verified correct) — the highest stated score in the table. The Decision selects A+D hybrid. The decision text explains why Phase 5A changes are proceeding (D-001, D-003, D-006 rationale is clear), but does not explain why Option B (partial adoption — consequence documentation without framing change) was not selected as the Phase 5A equivalent. The steelman for Option B ("isolates the component with the strongest independent justification from the component with the weakest evidence") is arguably better addressed by the chosen hybrid's Phase 5A component, but this alignment is not stated.

3. **Minor:** The Forces table includes "Phase 2 baseline contamination risk -- Opposes pre-Phase-2 implementation" but the Decision immediately proceeds with Phase 5A template changes. The text acknowledges this ("Phase 5A changes... are permitted before Phase 2 because they affect only the standard/template, not existing artifacts") but the Forces table does not show this as a resolved force — it remains listed as an opposing force without annotation that Phase 5A is scoped to avoid this risk.

**Improvement Path:**
- Correct Option C arithmetic (0.70 error) and add explicit paragraph in Decision section: "Option C has the highest weighted score under the comparative assessment. The hybrid is preferred because [explicit reason]."
- Add one sentence in Decision section directly comparing the hybrid's Phase 5A component to Option B and explaining why Option B (consequence documentation only, no framing) was not selected as the Phase 5A equivalent.
- Annotate the Forces table entry for "Phase 2 baseline contamination risk" to show it is resolved/mitigated by Phase 5A scope restriction.

---

### Methodological Rigor (0.87/1.00)

**Evidence:**
- Six adversarial strategies applied: S-002 (Devil's Advocate), S-003 (Steelman for all 4 options), S-004 (Pre-Mortem with 5 failure modes), S-010 (Self-Refine via H-15 checklist), S-012 (FMEA with 5 failure modes and RPN scoring), S-013 (Inversion). All documented in the Compliance section.
- FMEA RPN arithmetic verified correct (all 5 entries).
- Phase 2 dependency gate has quantitative GO/NO-GO criteria (pi_d 0.10-0.50, kappa >= 0.70, <= 4 execution failures).
- Four options evaluated with weighted scoring matrix (6 dimensions, weights summing to 1.00: 0.25+0.20+0.15+0.15+0.15+0.10=1.00 — verified correct).
- Tier-based sequencing for Phase 5B agent migration has explicit rationale.
- Orchestration Directives 4, 5, 6 explicitly inherited and applied.
- Pre-Mortem uses 5-column format (probability/impact/detection/mitigation) — more rigorous than typical.
- Inversion analysis reveals structural insight (consequence documentation is structurally bound to prohibition framing).

**Gaps:**

1. **Comparative Assessment cell values are asserted without derivation.** Option A "Evidence respect = 6 (T4 only)" is a judgment rendered as a number, but the 0-10 scale is not defined, no calibration anchor is provided, and the basis for each number is not documented. For a C4 deliverable, this is the primary methodological gap: the quantitative scoring table should either (a) document a calibration rubric for the 0-10 scale, or (b) acknowledge it is ordinal judgment and present it accordingly.

2. **Two arithmetic errors in the comparative scoring table (Option A: 6.50 vs. 6.55; Option C: 7.05 vs. 6.35)** undermine the table's credibility as a methodological tool. The Option C error is material and affects the decision rationale (see Internal Consistency above).

3. **The steelman for each option is provided, but Devil's Advocate is applied only in the Compliance section (one general challenge).** For a C4 ADR, per-option Devil's Advocate challenges would strengthen the methodology — particularly for the chosen hybrid, which is not explicitly steelmanned or devil's-advocated as a combination.

**Improvement Path:**
- Define a calibration rubric for the 0-10 option evaluation scale (e.g., 0=completely fails this dimension, 5=partially satisfies, 10=fully satisfies, with anchoring descriptions).
- Correct Option A and Option C arithmetic errors.
- Add a Devil's Advocate challenge specifically targeting the chosen hybrid (Phase 5A + conditional Phase 5B): "Why is a hybrid better than either pure Option B or pure Option C?"

---

### Evidence Quality (0.85/1.00)

**Evidence:**
- 13 evidence entries in the Evidence Register, all with tier labels (T1, T3, T4, or Internal synthesis) and explicit scope constraints.
- T1/T4 distinction maintained without exception. T4 evidence (VS-001 through VS-004) is never used to support causal claims — consistently labeled "observational" with explicit prohibition on conflation.
- A-11 excluded with documentation ("NEVER cite A-11. A-11 is a confirmed hallucinated citation").
- AGREE-5 labeled "Internally generated synthesis" with explicit "NOT externally validated" designation.
- VS-002 documents three competing causal explanations — preserves epistemic uncertainty rather than collapsing to a single interpretation.
- Evidence Boundaries table in Constraints section provides per-claim scope restrictions, including "NEVER conflate" language.
- PG-003 is correctly labeled "T4 observational, MEDIUM" (not T1).
- A-31 labeled T3 (arXiv) with scope constraint ("Reasoning tasks; 55% improvement signal on GPT-4") — appropriate for preprint-tier evidence.

**Gaps:**

1. **A-23 (Barreto & Jana, EMNLP 2025 Findings) tier justification is absent.** The "Findings" track at EMNLP is typically a shorter, non-archival paper type. Classifying it T1 without acknowledging the Findings-track distinction overstates its evidence weight relative to a full EMNLP proceedings paper. For a C4 deliverable, this distinction should be documented in the Evidence Register scope constraint field.

2. **Option comparative assessment cell values (e.g., "Evidence respect: Option A = 6") are undocumented judgments.** These influence the decision table that is presented as a methodological output, but the basis for each score is not cited or derived from any evidence source. Formally, these are internal assessments, not evidence — but they are presented in a quantitative format that implies evidence-based derivation.

3. **The Forces table cites "T1 (A-15, EMNLP 2024): Atomic decomposition improves compliance +7.3-8.0%"** without clarifying that the +7.3-8.0% is the improvement magnitude over a specific control condition. The Evidence Register scope constraint says "Compliance rate (+7.3-8.0%), NOT hallucination rate" but does not document the baseline or control condition. A reader cannot assess whether +7.3-8.0% is relative or absolute, or what the baseline compliance rate was.

**Improvement Path:**
- Add a note to A-23's Evidence Register entry: "EMNLP Findings track (short paper/non-archival); consider T1-minus rather than full T1 weight."
- Document the basis for comparative option cell scores either as a rubric footnote in the table or as a separate methodology note.
- Add baseline context to the A-15 citation in the Evidence Register (e.g., "improvement over structurally equivalent positive constraint baseline").

---

### Actionability (0.82/1.00)

**Evidence:**
- Phase 5A implementation is highly actionable: exact file paths given, before/after YAML code blocks for template update, format specification for VIOLATION labels, tier-differentiated table with T1/T2+/T5 rows, JSON schema additions with complete code.
- "What MUST NOT Happen Before Phase 2" is a concrete 4-item enumerated list that is immediately executable as a checklist.
- Phase 5B agent migration sequencing is actionable: three tiers with named agents in each tier (e.g., "ps-analyst, ps-researcher, ps-critic, orch-planner, nse-verification" for Tier 1; "eng-architect, eng-security, red-lead, red-recon, adv-executor, adv-scorer, sb-voice" for Tier 2).
- SKILL.md before/after format is specific: three-column table (Principle/Constraint/Consequence) with example content.
- NPT-010 and NPT-011 pattern templates are provided (markdown format strings).
- Phase 2 Dependency Gate GO/NO-GO criteria are quantitative and verifiable.

**Gaps:**

1. **Phase 5B NPT-010 and NPT-011 rule file targets are completely unspecified.** "Specific targets to be determined by Phase 2 findings and TASK-012 recommendation selection" (line 441) means that for 4 NPT-010 additions and 2 NPT-011 additions, there is no actionable implementation path from this document. An implementer would need to consult TASK-012 outputs to identify which rules receive these additions. For a C4 deliverable, candidate targets should be named (even if marked "provisional pending Phase 2").

2. **Phase 5B conditional branches under PG-003 null finding do not specify implementation steps.** Under "null framing effect" outcome, the ADR states "Implement consequence documentation only; NEVER-framing becomes convention-choice" for NPT-013 SKILL.md, but does not specify what the SKILL.md table would look like under this branch (i.e., no before/after template for the null-finding variant).

3. **D-002 (sequencing resolution) is decided as "new-agent-first, then backfill by maturity tier" but the criteria for advancing between tiers are not specified.** When does Tier 1 migration "complete" and Tier 2 begin? A CI gate trigger or a tracker threshold would make this actionable.

**Improvement Path:**
- Add a "Provisional Phase 5B NPT-010/NPT-011 Candidates" subsection identifying the 4 NPT-010 and 2 NPT-011 candidate rules from TASK-012, marked as provisional pending Phase 2.
- Add a before/after SKILL.md template variant for the PG-003 null finding path.
- Add tier advancement criteria for Phase 5B agent migration (e.g., "Tier 2 begins after all Tier 1 agents have `forbidden_action_format: NPT-009-complete` in their governance YAML").

---

### Traceability (0.88/1.00)

**Evidence:**
- Every sub-decision carries an identifier (D-001, D-002, D-003, D-004, D-006) with recommendation-level tracing (REC-F-001 through REC-F-003, REC-YAML-001/002).
- Evidence Register provides full provenance for all 13 cited evidence items, including source document, tier, scope constraint, and what the evidence is cited for.
- Phase 2 gate traces to TASK-005 (Orchestration Directive 6 source) and barrier-2/synthesis.md.
- PG-003 traces to barrier-2/synthesis.md ST-4.
- AGREE-5 traces to barrier-1/synthesis.md with quality gate score (0.953 PASS).
- Related Decisions table maps all 4 ADRs with relationship type (Prerequisite, Sibling, Downstream, Upstream) and status.
- PS Integration section provides worktracker linkage (PROJ-014, TASK-016).
- Compliance section traces each adversarial strategy (S-002 through S-013 selectively) to specific applications in the ADR.

**Gaps:**

1. **REC-F-002 and REC-F-003 are referenced in the Decision section and L1 Technical Implementation but their source TASK is not documented.** The Evidence Register traces A-15, VS-001, etc. to their sources, but the internal recommendations (REC-F-001 through REC-F-003, REC-YAML-001/002) have no documented origin in the Evidence Register. A reader cannot determine whether these were generated by TASK-010, TASK-011, or TASK-012 analysis.

2. **The comparative assessment dimension weights (0.25/0.20/0.15/0.15/0.15/0.10) are asserted without tracing to a source.** Who determined that "Evidence respect" should have weight 0.25 and "Framework consistency" weight 0.20? For a C4 decision, this weighting should be traced to a decision principle or documented as an explicit ADR author judgment.

3. **D-005 is missing from the sub-decision sequence.** The Decision section enumerates D-001, D-002, D-003, D-004, D-006 — there is no D-005. This gap in the numbering is unexplained and may indicate a dropped sub-decision or a numbering error.

**Improvement Path:**
- Add "Source Task" column to the Evidence Register for internal recommendation IDs (REC-F-001 through REC-YAML-002).
- Add a footnote to the comparative assessment weight selection: "Weights selected by ps-architect to reflect [rationale]; see [source if any]."
- Resolve the D-005 numbering gap: either document that D-005 was considered and rejected (with brief rationale), or renumber to close the gap.

---

## Improvement Recommendations (Priority Ordered)

| Priority | Dimension | Finding | Current | Target | Recommendation |
|----------|-----------|---------|---------|--------|----------------|
| 1 | Internal Consistency / Methodological Rigor | Option C arithmetic error: stated 6.35, computed 7.05 (0.70 error). Option A arithmetic error: stated 6.55, computed 6.50 (0.05 error). Under correct arithmetic, Option C has the highest weighted score, which directly undermines the decision rationale. | Errors present | Corrected | Fix both arithmetic errors in the comparative scoring table. Add explicit paragraph in Decision explaining why the hybrid is preferred over Option C (which has the highest correct weighted score) and Option B (which scores 7.00 as stated). |
| 2 | Actionability | Phase 5B NPT-010/NPT-011 rule file targets unspecified | No targets named | Provisional candidates named | Add "Provisional NPT-010/NPT-011 Candidate Rules" subsection drawing from TASK-012 output, identifying the 4 NPT-010 and 2 NPT-011 target rules/files marked as provisional pending Phase 2 confirmation. |
| 3 | Methodological Rigor / Evidence Quality | Comparative option scoring 0-10 scale is undocumented and underivedition. Cell values are asserted judgments presented in quantitative format. | No rubric | Calibration documented | Add a scoring rubric footnote to the Comparative Assessment table (e.g., "0=completely fails dimension, 5=partially satisfies, 10=fully satisfies") and document the basis for each option's score in the most consequential cells (Evidence respect, Phase 2 baseline safety). |
| 4 | Traceability | D-005 numbering gap unexplained | Gap in D-001/D-002/D-003/D-004/D-006 sequence | Gap resolved | Add a brief entry documenting D-005: either a rejected sub-decision or a clarification that D-005 does not exist (renumber if applicable). |
| 5 | Traceability | REC-F-002/REC-F-003 source task not traceable | No source in Evidence Register | Source documented | Add "Source Task" column to Evidence Register for internal recommendations, or add footnotes in the Decision section citing which TASK generated REC-F-001 through REC-YAML-002. |
| 6 | Evidence Quality | A-23 (EMNLP 2025 Findings track) tier not justified | T1 asserted | T1 with qualification | Add a note to the A-23 Evidence Register entry distinguishing EMNLP Findings track from full proceedings and adjusting the scope constraint to reflect lower evidence weight. |
| 7 | Actionability | Phase 5B null-finding implementation variant not specified | No before/after template for PG-003 path | Variant template provided | Add a brief before/after SKILL.md template variant showing what the Constitutional Compliance section would look like under the PG-003 null finding path (consequence documentation retained, NEVER verb replaced with positive equivalent). |
| 8 | Internal Consistency / Actionability | Tier advancement criteria for Phase 5B agent migration unspecified | No trigger defined | CI gate or tracker threshold named | Add advancement criteria for moving from Tier 1 to Tier 2 to Tier 3 migration (e.g., "Tier 2 begins after all Tier 1 agents have `forbidden_action_format: NPT-009-complete` in governance YAML and CI validation passes"). |

---

## Leniency Bias Check

- [x] Each dimension scored independently before computing composite
- [x] Evidence documented for each score with specific line/section references
- [x] Uncertain scores resolved downward (Actionability at 0.82 rather than 0.85 despite strong Phase 5A content, due to Phase 5B gaps)
- [x] C4 calibration applied: 0.853 for a first-draft C4 ADR with genuine structural completeness but material arithmetic errors and underspecified Phase 5B targets is appropriate (not lenient)
- [x] No dimension scored above 0.90 without exceptional evidence
- [x] Arithmetic errors independently verified before scoring (Option C: 7.05 vs stated 6.35; Option A: 6.50 vs stated 6.55)
- [x] AGREE-5 not accepted as T1/T3 evidence per scoring instruction
- [x] A-11 confirmed not cited (PASS)

**Anti-leniency check:** The gate checks all pass, which could tempt a lenient scorer toward PASS at the H-13 threshold (0.92). This score resists that pull: the arithmetic errors in the comparative assessment are factual errors in the core methodological tool of the ADR, the Option C score understatement is material to the decision rationale, and Phase 5B actionability gaps are genuine for a C4 deliverable. The 0.853 composite reflects genuine quality — strong structure and evidence discipline — with specific, correctable deficiencies.

---

## Session Context Protocol

```yaml
verdict: REVISE
composite_score: 0.853
threshold: 0.95
weakest_dimension: actionability
weakest_score: 0.82
critical_findings_count: 0
material_findings_count: 2
iteration: 1
improvement_recommendations:
  - "Fix arithmetic errors in Comparative Assessment table (Option C: 6.35->7.05, Option A: 6.55->6.50); add explicit Decision rationale for hybrid over Option C and Option B"
  - "Add provisional Phase 5B NPT-010/NPT-011 candidate rule targets from TASK-012 output"
  - "Add 0-10 scoring rubric to Comparative Assessment table"
  - "Resolve D-005 numbering gap"
  - "Add source task to Evidence Register for REC-F-001 through REC-YAML-002"
  - "Qualify A-23 as EMNLP Findings track in Evidence Register"
  - "Add null-finding branch before/after template for SKILL.md Constitutional Compliance"
  - "Add Tier advancement criteria for Phase 5B agent migration"
```
